Compare Stocks: TKNO, CYRX, EVO, and MLAB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYRX CryoPort	$16.34 -4.6%	$15.54	$7.61 ▼ $17.20	$867.62M	1.89	589,124 shs	493,271 shs
EVO Evotec	$1.89 -2.1%	$2.28	$1.89 ▼ $4.27	$686.73M	1.96	70,062 shs	22,641 shs
MLAB Mesa Laboratories	$124.32 -0.4%	$101.87	$58.83 ▼ $125.30	$698.14M	0.92	158,426 shs	148,315 shs
TKNO Alpha Teknova	$7.34 -0.3%	$5.76	$1.91 ▼ $7.84	$394.60M	0.64	270,287 shs	180,058 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYRX CryoPort	0.00%	+12.33%	+11.45%	+22.36%	+90.97%
EVO Evotec	0.00%	-1.53%	-0.52%	-36.30%	-46.98%
MLAB Mesa Laboratories	0.00%	+17.65%	+27.96%	+14.84%	+71.00%
TKNO Alpha Teknova	0.00%	+0.96%	+48.09%	+89.20%	+54.95%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYRX CryoPort	$16.34 -4.6%	$15.54	$7.61 ▼ $17.20	$867.62M	1.89	589,124 shs	493,271 shs
EVO Evotec	$1.89 -2.1%	$2.28	$1.89 ▼ $4.27	$686.73M	1.96	70,062 shs	22,641 shs
MLAB Mesa Laboratories	$124.32 -0.4%	$101.87	$58.83 ▼ $125.30	$698.14M	0.92	158,426 shs	148,315 shs
TKNO Alpha Teknova	$7.34 -0.3%	$5.76	$1.91 ▼ $7.84	$394.60M	0.64	270,287 shs	180,058 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYRX CryoPort	0.00%	+12.33%	+11.45%	+22.36%	+90.97%
EVO Evotec	0.00%	-1.53%	-0.52%	-36.30%	-46.98%
MLAB Mesa Laboratories	0.00%	+17.65%	+27.96%	+14.84%	+71.00%
TKNO Alpha Teknova	0.00%	+0.96%	+48.09%	+89.20%	+54.95%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CYRX CryoPort	2.67	Moderate Buy	$18.00	10.23% Upside
EVO Evotec	2.20	Hold	$3.00	58.65% Upside
MLAB Mesa Laboratories	2.00	Hold	$110.00	-11.47% Downside
TKNO Alpha Teknova	2.25	Hold	$7.50	1.86% Upside

Current Analyst Ratings Breakdown

Latest TKNO, CYRX, EVO, and MLAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	CYRX CryoPort	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D)
8/14/2026	MLAB Mesa Laboratories	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$94.00 ➝ $110.00
8/11/2026	MLAB Mesa Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Hold (C-)
8/11/2026	TKNO Alpha Teknova	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/11/2026	TKNO Alpha Teknova	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$8.00
8/7/2026	CYRX CryoPort	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $16.00
8/7/2026	CYRX CryoPort	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$21.00
8/7/2026	CYRX CryoPort	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
8/6/2026	TKNO Alpha Teknova	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
8/5/2026	TKNO Alpha Teknova	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
8/5/2026	TKNO Alpha Teknova	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00

(Data available from 8/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CYRX CryoPort	$176.18M	4.69	N/A	N/A	$9.19 per share	1.78
EVO Evotec	$717.28M	0.94	N/A	N/A	$2.59 per share	0.73
MLAB Mesa Laboratories	$249.13M	2.79	$11.72 per share	10.60	$33.71 per share	3.69
TKNO Alpha Teknova	$40.52M	9.74	N/A	N/A	$1.28 per share	5.75

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CYRX CryoPort	$78.30M	-$0.90	N/A	N/A	N/A	-20.05%	-7.20%	-4.30%	11/3/2026 (Estimated)
EVO Evotec	-$117.12M	N/A	N/A	N/A	N/A	-26.20%	-24.93%	-11.35%	11/5/2026 (Estimated)
MLAB Mesa Laboratories	$6.71M	$0.84	147.92	N/A	N/A	1.92%	22.72%	9.82%	11/5/2026 (Estimated)
TKNO Alpha Teknova	-$17.26M	-$0.31	N/A	N/A	N/A	-38.37%	-24.94%	-16.53%	11/5/2026 (Estimated)

Latest TKNO, CYRX, EVO, and MLAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q1 2027	MLAB Mesa Laboratories	N/A	$2.68	N/A	$0.49	N/A	$60.14 million
8/6/2026	Q2 2026	CYRX CryoPort	-$0.1933	-$0.20	-$0.0067	-$0.20	$48.18 million	$48.97 million
8/5/2026	Q2 2026	TKNO Alpha Teknova	-$0.0843	-$0.06	+$0.0243	-$0.06	$10.95 million	$12.19 million
5/27/2026	Q4 2026	MLAB Mesa Laboratories	$1.78	$1.53	-$0.25	-$0.75	$65.21 million	$63.72 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CYRX CryoPort	N/A	N/A	N/A	N/A	N/A
EVO Evotec	N/A	N/A	N/A	N/A	N/A
MLAB Mesa Laboratories	$0.64	0.51%	N/A	76.19%	N/A
TKNO Alpha Teknova	N/A	N/A	N/A	N/A	N/A

Latest TKNO, CYRX, EVO, and MLAB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/6/2026	MLAB Mesa Laboratories	quarterly	$0.16	0.62%	8/31/2026	8/31/2026	9/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CYRX CryoPort	N/A	2.08	1.98
EVO Evotec	0.62	2.33	2.21
MLAB Mesa Laboratories	0.73	1.79	1.32
TKNO Alpha Teknova	0.21	4.49	3.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CYRX CryoPort	92.90%
EVO Evotec	5.81%
MLAB Mesa Laboratories	90.60%
TKNO Alpha Teknova	13.81%

Insider Ownership

Company	Insider Ownership
CYRX CryoPort	9.50%
EVO Evotec	1.00%
MLAB Mesa Laboratories	2.80%
TKNO Alpha Teknova	13.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CYRX CryoPort	1,186	50.65 million	45.84 million	Optionable
EVO Evotec	4,553	355.76 million	N/A	Not Optionable
MLAB Mesa Laboratories	680	5.60 million	5.44 million	Not Optionable
TKNO Alpha Teknova	240	53.61 million	46.54 million	Not Optionable

TKNO, CYRX, EVO, and MLAB Headlines

Recent News About These Companies

Alpha Teknova: Ample Manufacturing Capacity At A High Premium

August 24 at 9:19 AM | seekingalpha.com

Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference

August 19, 2026 | marketbeat.com

Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy?

August 19, 2026 | zacks.com

Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade

August 10, 2026 | zacks.com

Alpha Teknova (NASDAQ:TKNO) Raised to Hold at Zacks Research

August 8, 2026 | marketbeat.com

Alpha Teknova (NASDAQ:TKNO) Upgraded at Wall Street Zen

August 8, 2026 | marketbeat.com

Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand

August 7, 2026 | insidermonkey.com

Teknova targets less than $8M 2026 free cash outflow as it lifts revenue guide to $45M-$47M

August 6, 2026 | seekingalpha.com

Roth Capital Upgrades Alpha Teknova (NASDAQ:TKNO) to Strong-Buy

August 6, 2026 | marketbeat.com

Alpha Teknova Q2 Earnings Call Highlights

August 6, 2026 | marketbeat.com

Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results, Beats Estimates By $0.02 EPS

August 5, 2026 | marketbeat.com

Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes

August 5, 2026 | markets.businessinsider.com

Teknova Reports Second Quarter 2026 Financial Results

August 5, 2026 | globenewswire.com

Alpha Teknova (TKNO) to Release Quarterly Earnings on Wednesday

July 29, 2026 | marketbeat.com

Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026 | globenewswire.com

Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), Arcus Biosciences (RCUS) and Tenaya Therapeutics (TNYA)

June 4, 2026 | theglobeandmail.com

Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)

May 9, 2026 | theglobeandmail.com

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 9, 2026 | finance.yahoo.com

Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript

May 8, 2026 | seekingalpha.com

Alpha Teknova Charts Cautious Path to 2027 Growth

May 7, 2026 | tipranks.com

Alpha Teknova (TKNO) Q1 2026 Earnings Transcript

May 6, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TKNO, CYRX, EVO, and MLAB Company Descriptions

CryoPort NASDAQ:CYRX

$16.34 -0.79 (-4.61%)

Closing price 04:00 PM Eastern

Extended Trading

$16.33 -0.01 (-0.06%)

As of 06:01 PM Eastern

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Evotec NASDAQ:EVO

$1.89 -0.04 (-2.07%)

Closing price 04:00 PM Eastern

Extended Trading

$1.93 +0.04 (+2.01%)

As of 06:56 PM Eastern

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Mesa Laboratories NASDAQ:MLAB

$124.32 -0.44 (-0.35%)

Closing price 04:00 PM Eastern

Extended Trading

$124.55 +0.23 (+0.18%)

As of 06:14 PM Eastern

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Alpha Teknova NASDAQ:TKNO

$7.34 -0.02 (-0.27%)

Closing price 04:00 PM Eastern

Extended Trading

$7.28 -0.06 (-0.82%)

As of 05:05 PM Eastern

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TKNO, CYRX, EVO, and MLAB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TKNO, CYRX, EVO, and MLAB Earnings

Compare Dividends

Latest TKNO, CYRX, EVO, and MLAB Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TKNO, CYRX, EVO, and MLAB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TKNO, CYRX, EVO, and MLAB Company Descriptions

CryoPort NASDAQ:CYRX

Evotec NASDAQ:EVO

Mesa Laboratories NASDAQ:MLAB

Alpha Teknova NASDAQ:TKNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools